牙科中的粘液瘤病

Ankit Shah, Naiya Shah, Shivangi Joshi
{"title":"牙科中的粘液瘤病","authors":"Ankit Shah, Naiya Shah, Shivangi Joshi","doi":"10.36106/gjra/9406936","DOIUrl":null,"url":null,"abstract":"Mucormycosis is a fungal infection, caused by mucorales which are lamentous molds, found\npredominantly in the immune-compromised patients. Mucorales have a natural susceptibility which are\nkilled by human phagocytes, that eventually exaggerates its virulent power. some belonging genera of mucorales are rhizopus,\nlichtheimia mucor, cunninghamella, rhizomucor. This article will dwealth into the classication, signs & symptoms, oral\nmanifestations, risk factors, pathogenesis, stages of mucormycosis, early diagnosis and treatment which will reduce the\nmortality and morbidity of fatal fungal infection. The prevelancy of the disease states that about 70-75% higher cases are\nrecorded in india in comparable to all the other countries globally. It is also seen than only 6 to 10 % of the cases occur in the\nsubjects with no underlying disease or cause as in contrast it usually affects immunocompromised human bodies with poorly\ncontrolled diabetes and hypertensive patients. The fungi invades the blood vessels leading to thrombosis, necrosis and\ninfarction of the tissue. Mucormycosis can progress rapidly and it may delay the initiation of the treatment in even few days and\nmay lead to worst consequences. The primary line of treatment is amphotericin B, the newer triazoles, posaconazole and\nisavuconazole can be effective in patients who are resistant towards the amphotericin B. early surgical excision plays a pivotal\nrole in the management of the mucormycosis.","PeriodicalId":12664,"journal":{"name":"Global journal for research analysis","volume":"10 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MUCORMYCOSIS IN DENTISTRY\",\"authors\":\"Ankit Shah, Naiya Shah, Shivangi Joshi\",\"doi\":\"10.36106/gjra/9406936\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Mucormycosis is a fungal infection, caused by mucorales which are lamentous molds, found\\npredominantly in the immune-compromised patients. Mucorales have a natural susceptibility which are\\nkilled by human phagocytes, that eventually exaggerates its virulent power. some belonging genera of mucorales are rhizopus,\\nlichtheimia mucor, cunninghamella, rhizomucor. This article will dwealth into the classication, signs & symptoms, oral\\nmanifestations, risk factors, pathogenesis, stages of mucormycosis, early diagnosis and treatment which will reduce the\\nmortality and morbidity of fatal fungal infection. The prevelancy of the disease states that about 70-75% higher cases are\\nrecorded in india in comparable to all the other countries globally. It is also seen than only 6 to 10 % of the cases occur in the\\nsubjects with no underlying disease or cause as in contrast it usually affects immunocompromised human bodies with poorly\\ncontrolled diabetes and hypertensive patients. The fungi invades the blood vessels leading to thrombosis, necrosis and\\ninfarction of the tissue. Mucormycosis can progress rapidly and it may delay the initiation of the treatment in even few days and\\nmay lead to worst consequences. The primary line of treatment is amphotericin B, the newer triazoles, posaconazole and\\nisavuconazole can be effective in patients who are resistant towards the amphotericin B. early surgical excision plays a pivotal\\nrole in the management of the mucormycosis.\",\"PeriodicalId\":12664,\"journal\":{\"name\":\"Global journal for research analysis\",\"volume\":\"10 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global journal for research analysis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36106/gjra/9406936\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal for research analysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36106/gjra/9406936","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

粘孢子菌病是由粘孢子菌引起的真菌感染,粘孢子菌属于  丝状霉菌,主要存在于免疫力低下的患者中。粘菌有一种天然的易感性,会被人类吞噬细胞杀死,从而最终增强其毒性。粘菌的一些属包括根瘤菌属、粘菌立枯丝核菌属、粘菌阴干菌属、粘菌根瘤菌属。本文将深入探讨粘孢子菌病的分类cation、症状和体征、口腔表现、危险因素、发病机制、发病阶段、早期诊断和治疗,从而降低致命真菌感染的死亡率和发病率。该疾病的发病率表明,与全球所有其他国家相比,印度的发病率高出约 70-75%。此外,只有 6% 到 10% 的病例发生在没有潜在疾病或病因的受试者身上,相反,它通常会影响免疫力低下的人体、控制不佳的糖尿病患者和高血压患者。真菌侵入血管会导致血栓形成、组织坏死和梗死。粘孢子菌病的病情发展迅速,甚至几天内就会延误治疗,并可能导致最严重的后果。治疗的主要方法是两性霉素 B,新的三唑类药物、泊沙康唑和异唑康唑对两性霉素 B 耐药的患者有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
MUCORMYCOSIS IN DENTISTRY
Mucormycosis is a fungal infection, caused by mucorales which are lamentous molds, found predominantly in the immune-compromised patients. Mucorales have a natural susceptibility which are killed by human phagocytes, that eventually exaggerates its virulent power. some belonging genera of mucorales are rhizopus, lichtheimia mucor, cunninghamella, rhizomucor. This article will dwealth into the classication, signs & symptoms, oral manifestations, risk factors, pathogenesis, stages of mucormycosis, early diagnosis and treatment which will reduce the mortality and morbidity of fatal fungal infection. The prevelancy of the disease states that about 70-75% higher cases are recorded in india in comparable to all the other countries globally. It is also seen than only 6 to 10 % of the cases occur in the subjects with no underlying disease or cause as in contrast it usually affects immunocompromised human bodies with poorly controlled diabetes and hypertensive patients. The fungi invades the blood vessels leading to thrombosis, necrosis and infarction of the tissue. Mucormycosis can progress rapidly and it may delay the initiation of the treatment in even few days and may lead to worst consequences. The primary line of treatment is amphotericin B, the newer triazoles, posaconazole and isavuconazole can be effective in patients who are resistant towards the amphotericin B. early surgical excision plays a pivotal role in the management of the mucormycosis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信